Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD3 | Q9NY59 | 13/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.78 |
| ▸ | HPGD | P15428 | 6/20 | 0.78 |
| ▸ | MEN1 | O00255 | 4/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.78 |
| ▸ | GAA | P10253 | 2/20 | 0.78 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 3/20 | 0.53 |
| ▸ | NCOA2 | Q15596 | 3/20 | 0.53 |
| ▸ | NCOA1 | Q15788 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24344005 | 0.93 | SMPD3 (0.87) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL22291076 | 0.88 | MAPT (0.82) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL22291134 | 0.88 | SMPD3 (1.00) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL22291127 | 0.85 | SMPD3 (1.00) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL22301592 | 0.85 | SMPD3 (1.00) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL22291070 | 0.82 | SMPD3 (1.00) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL12106316 | 0.80 | SMPD3 (1.00) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL21315904 | 0.79 | SMPD3 (0.85) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL30111705 | 0.78 | MAPT (0.74) | SMPD3MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL30111647 | 0.76 | MAPT (0.79) | SMPD3MAPTKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220119374-A1 | SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (nSMase2) INHIBITORS | THE JOHNS HOPKINS UNIVERSITY | 2022-04-21 | — | — | US | disclosed |
| EP-3917530-A1 | SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (NSMASE2) INHIBITORS | The Johns Hopkins University (US) | 2021-12-08 | — | — | EP | disclosed |
| WO-2020160148-A1 | SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (NSMASE2) INHIBITORS | THE JOHNS HOPKINS UNIVERSITY (US) | 2020-08-06 | — | — | WO | disclosed |
| WO-2020160148-A1 | SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (NSMASE2) INHIBITORS | THE JOHNS HOPKINS UNIVERSITY (US) | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119374-A1 | SMALL MOLECULE NEUTRAL SPHINGOMYELINASE 2 (nSMase2) INHIBITORS | SMPD2, SPTLC2, SGMS2 | SMPD3 8/4885MAPT 120/4885KDM4E 1559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.